Chevron Left
Back to Drug Commercialization

Learner Reviews & Feedback for Drug Commercialization by University of California San Diego

4.7
stars
1,284 ratings

About the Course

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you
lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in
the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing
strategy, intellectual property strategy, portfolio management, managed markets and strategic alliances. It will also have a lecture case study
from startup to success. In addition, the course will discuss post-marketing clinical trials or Phase 4 trials. These are conduct...
...

Top reviews

JR

Jan 7, 2017

Excellent course on strategies for drug commercialization including pharmacoeconomics and how pharma partners with other stakeholders to accomplish this. Excellent examples of drug lifecycles.

AZ

Nov 9, 2020

Excellent content and lecturers. Great course to finish this specialization. I strongly recommend the three courses for those interested in pursuing a career in pharma or willing to shift.

Filter by:

226 - 243 of 243 Reviews for Drug Commercialization

By Kierstin L

Aug 23, 2017

Etouillie was great and his experience commentary made the course more interesting. His biosimilar section is highly pertinent to the US current situation with lawsuits flying every which way. I do wish more regulatory process steps were included. The start up success last section was not helpful. More just seemed like a quick review article one could read about an approved drug and the story of someone bragging about how lucky they were.

By Danna F M

Sep 29, 2019

The course was very interesting and cover differents topics to give me an overview of drug commercialization in USA. In addition, the experiences shared from the each professor was excelent. However, I didn't know that the majority of topics were made in 2013. So this information was missing when I applied for this course.

By George L

Mar 7, 2021

I found this course to be very engaging and informative about the Drug Development Process. However, most of the information is outdated - the course was recorded in 2015 and a lot has changed in pharma since then. I would give it a 5-stare rating if I had taken the course say 4-5 years ago.

By Dei M M L

Dec 26, 2021

It is an excellent course from Coursera for learning on strategies for drug commercialization including pharmacoeconomics and how pharmaceuticals partners with other stakeholders to accomplish this.

By Alexander B

Nov 2, 2020

Most of materials are quite outdated and also quality of presentations sometimes was not that good.

By Richik N M

Jul 19, 2020

Not enough materials on HEOR and Phase IV studies. Week 4's lectures were redundant.

By Saudamini R

Jun 8, 2020

Its a wonderful course, but i would request the faculty to include more recent data

By m_taisir k

Oct 24, 2017

some lectures are not understand

but generally

thank you

By Meg R

Jun 27, 2024

The managed markets data was old, needs to be updated.

By vincent l

Feb 19, 2018

It was alright, couldve given more examples and cases

By yousef e

Sep 29, 2019

i think part one in week 4 is too bad

By Deleted A

Jun 2, 2019

Audio ruim

By mark y

May 27, 2024

goodsir

By 普信男版Gary

Apr 17, 2024

So so

By Nisha k

Nov 3, 2022

good

By Hilal T

Sep 10, 2024

ok

By Deleted A

Sep 14, 2022

Outdated series of classes that offer no real learning opportunities.

By Se a

Jan 1, 2023

The course needs to be updated with much newer lectures.

The sound quality in a lot of the lectures was quite bad.